Meisam Bagheri

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Dna Methylation

Top Venues

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, Todd W Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. bioRxiv : the preprint server for biology (2023)